This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (5)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in JAMA  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor.—We read with interest the recent presentation and review of a case of Salmonella typhi infection in a pregnant woman returning from India. Dr Zenilman¹ discussed multidrug resistance (MDR) in S typhi and reinforced the general view that fluoroquinolones are effective first-line therapy in the treatment of such infections.

We recently cared for a 52-year-old man who had arrived 1 week previously from the Punjab region of northern India. He had had fever and headache for 6 days. Blood cultures grew S typhi, and he was treated with oral ciprofloxacin (500 mg twice a day at presentation, increasing to 750 mg twice a day on day 3). Despite some clinical improvement he remained febrile after 17 days of treatment. Ceftriaxone, 1 g once daily, was added to his regimen, and his fever resolved within 3 days.

The S typhi isolate was sensitive in vitro to trimethoprim, ampicillin, . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Typhoid Fever
Jonathan M. Zenilman
JAMA. 1997;278(10):847-850.
PDF  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Typhoid Fever in the United States, 1999-2006
Lynch et al.
JAMA 2009;302:859-865.
ABSTRACT | FULL TEXT  

Laboratory-Based Surveillance of Salmonella Serotype Typhi Infections in the United States: Antimicrobial Resistance on the Rise
Ackers et al.
JAMA 2000;283:2668-2673.
ABSTRACT | FULL TEXT